Total Voting Rights
18 December, 2006
Multi-Target Genentech Agreement
20 November, 2006
Sareum Issue of Equity
30 October, 2006
Board Change
19 October, 2006
AGM Statement
19 October, 2006
Research Collaboration with PIramed Ltd
09 October, 2006
Cancer Collaboration with Roche
26 September, 2006
Sareum Posting of Accounts
25 September, 2006
Annual Results 2006
04 September, 2006
Novel Compounds Discovered In Cancer Drug Discovery Collaboration
31 August, 2006
Second Collaboration with Lundbeck A/S
15 August, 2006
Extension of Collaboration with Almirall Prodesfarma S.A.
13 July, 2006
Collaboration with Sirtris Pharmaceuticals
20 June, 2006
Sareum Holding(s) in Company
14 June, 2006
Success Milestones Reached in Collaboration with Schering AG
08 June, 2006
Financial Results
23 February, 2006
$5M Research Collaboration with Idenix Pharmaceuticals, Inc.
09 February, 2006
Crystal Bank Collaboration with UCB
26 January, 2006
Sareum Announce Collaboration with Lundbeck A/S
19 January, 2006
Organon & Sareum Announce Research Collaboration in Autoimmune Disease
17 January, 2006
BCL-2, an Important Oncology Protein Structure, added to Crystal Bank
12 January, 2006
Collaboration with Idenix Pharmaceuticals, Inc.
10 January, 2006
Trading Update
05 January, 2006
Previous releases
2010 2009 2008 2007 2006 2005 2004
News feed
requires RSS news reader
9 September 2010
Sareum Holdings Plc
(“the Company”)
Holdings in Company
The Company announces, following notification received yesterday, that Barclays PLC no longer holds a notifiable interest in the capital of the Company.
Enquiries:
|
Sareum Holdings plc |
|
|
Tim Mitchell |
01223 497 700 |
|
Merchant Securities Limited |
|
|
Simon Clements/Bidhi Bhoma |
020 7628 2200 |
|
Hybridan LLP |
|
|
Claire Noyce |
020 7947 4350 |
Requires MS Word
Requires Adobe Acrobat Reader